XML 116 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative financial instruments and market risks (Tables)
 12 Months Ended
Dec. 31, 2022
Financial Instruments [Abstract]  
Summary of Fair Value of Derivative Instruments
The table below shows the fair value of derivative instruments as of December 31, 2022, 2021 and 2020:
(€ million)
Non-current
assets
Current
assets		Total
assets		Non-current
liabilities		Current
liabilities		Total
liabilities		Market value at December 31, 2022 (net)Market value at December 31, 2021 (net)Market value at December 31, 2020 (net)
Currency derivatives— 206 206 — (94)(94)112 222 (209)
operating— 88 88 — (66)(66)22 10 7 
financial— 118 118 — (28)(28)90 212 (216)
Interest rate derivatives— — — (232)— (232)(232)7 20 
Equity derivatives— — — — — — — (16)(26)
Total— 206 206 ( 232)( 94)( 326)( 120)213 ( 215)
Summary of Operating Currency Hedging Instruments
The table below shows operating currency hedging instruments in place as of December 31, 2022, with the notional amount translated into euros at the relevant closing exchange rate:
December 31, 2022Of which derivatives designated as
cash flow hedges		Of which derivatives not
eligible for hedge accounting
(€ million)Notional
amount		Fair
value		Notional
amount		Fair
value		Of which
recognized in equity		Notional
amount		Fair value
Forward currency sales5,403 49 — — — 5,403 49 
of which US dollar2,732 56 — — — 2,732 56 
of which Chinese yuan renminbi576 2 — — — 576 2 
of which Japanese yen240 (5)— — — 240 (5)
of which Singapore dollar180 1 — — — 180 1 
of which Korean won179 (14)— — — 179 (14)
Forward currency purchases3,459 (27)— — — 3,459 (27)
of which US dollar2,047 (21)— — — 2,047 (21)
of which Singapore dollar375 (7)— — — 375 (7)
of which Chinese yuan renminbi142 — — — — 142 — 
of which Korean won130 4 — — — 130 4 
of which Taiwan dollar84 — — — — 84 — 
Total8,862 22 — — — 8,862 22 
The table below shows operating currency hedging instruments in place as of December 31, 2021, with the notional amount translated into euros at the relevant closing exchange rate:
December 31, 2021Of which derivatives designated as
cash flow hedges		Of which derivatives not
eligible for hedge accounting
(€ million)Notional
amount		Fair
value		Notional
amount		Fair
value		Of which
recognized in equity		Notional
amount		Fair value
Forward currency sales3,912 4 –––3,912 4 
of which US dollar1,392 5 –––1,392 5 
of which Chinese yuan renminbi665 (2)–––665 (2)
of which Singapore dollar355 (1)–––355 (1)
of which Japanese yen199 3 –––199 3 
of which Taiwan dollar122 (1)–––122 (1)
Forward currency purchases2,374 6 –––2,374 6 
of which US dollar833 (2)–––833 (2)
of which Singapore dollar696 7 –––696 7 
of which Chinese yuan renminbi255 — –––255 — 
of which Hungarian forint77 — –––77 — 
of which Russian rouble72 (1)–––72 (1)
Total6,286 10 –––6,286 10 
The table below shows operating currency hedging instruments in place as of December 31, 2020, with the notional amount translated into euros at the relevant closing exchange rate:
December 31, 2020Of which derivatives
designated as cash flow hedges
Of which derivatives not
eligible for hedge accounting
(€ million)Notional
amount		Fair
value		Notional
amount		Fair
value		Of which
recognized
in equity		Notional
amount		Fair value
Forward currency sales3,477 7 — — — 3,477 7 
of which US dollar1,367 10 — — — 1,367 10 
of which Chinese yuan renminbi521 2 — — — 521 2 
of which Singapore dollar287 (1)— — — 287 (1)
of which Japanese yen143 1 — — — 143 1 
of which Mexican peso121 — — — — 121 — 
Forward currency purchases1,932 — — — — 1,932 — 
of which US dollar580 (1)— — — 580 (1)
of which Singapore dollar571 (1)— — — 571 (1)
of which Chinese yuan renminbi286 1 — — — 286 1 
of which Russian rouble61 — — — — 61 — 
of which Japanese yen55 — — — — 55 — 
Total5,409 7 — — — 5,409 7 
Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated
The table below shows financial currency hedging instruments in place, with the notional amount translated into euros at the relevant closing exchange rate:
202220212020
(€ million)Notional
amount		Fair
value		ExpiryNotional
amount		Fair
value		ExpiryNotional
amount		Fair
value		Expiry
Forward currency sales7,559 66 7,655 15 5,064 10 
of which US dollar6,114 (a)59 20235,384 23 20223,721 20 2021
of which Pound sterling384 7 2023309 (2)2022257 (6)2021
of which Chinese yuan renminbi203 2 202370 (2)202226 — 2021
Forward currency purchases4,997 24 9,293 197 9,004 (226)
of which US dollar2,011 (b) (c)(4)20234,816 128 20226,068 (200)2021
of which Singapore dollar2,154 (d)22 20232,910 75 20222,250 (27)2021
of which Japanese yen205 4 2023235 (2)202268 — 2021
Total12,556 90 16,948 212 14,068 (216)
(a) Includes forward sales with a notional amount of $3,615 million expiring in 2023, designated as a hedge of Sanofi’s net investment in Bioverativ. As of December 31, 2022, the fair value of these forward contracts represented an asset of €38 million; the opposite entry was recognized in "Other comprehensive income", with the impact on financial income and expense being immaterial.
(b) Includes forward purchases with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of €3 million, the opposite entry for €0.6 million of which was debited to “Other comprehensive income” under the cost of hedging accounting treatment.
(c) Includes receiver currency swaps with a notional amount of $1,000 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/USD spot rate. As of December 31, 2022, the fair value of the swaps was a liability of €2 million, the opposite entry for €1.4 million of which was credited to “Other comprehensive income” under the cost of hedging accounting treatment.
(d) Includes forward purchases with a notional amount of SGD1,500 million expiring in 2023, designated as a fair value hedge of the exposure of an equivalent amount of intragroup current accounts to fluctuations in the EUR/SGD spot rate. As of December 31, 2022, the fair value of the contracts was an asset of €33 million, the opposite entry for €2.5 million of which was credited to “Other comprehensive income” under the cost of hedging accounting treatment
Disclosure of Instruments
The table below shows interest rate hedging instruments in place as of December 31, 2022:
Notional amounts by expiry date as of December 31, 2022Of which
designated as
fair value
hedges		Of which designated as
cash flow hedges
(€ million)202320242025202620272028 and laterTotalFair
value		Notional
amount		Fair
value		Notional
amount		Fair
value		Of which
recognized
in equity
Interest rate swaps
pay SOFR USD/receive 1.03%
— — — — — 467 467 (62)467 (62)— — — 
pay SOFR USD/receive 1.32%
— — — — — 467 467 (56)467 (56)— — — 
pay capitalized Ester/receive 0.69%
— — 850 — — — 850 (43)850 (43)———
pay capitalized Ester/receive 0.92%
— — — — — 650 650 (71)650 (71)———
Total— — 850 — — 1,584 2,434 (232)2,434 (232)— — — 
The table below shows interest rate hedging instruments in place as of December 31, 2021:
Notional amounts by expiry date as of December 31, 2021Of which
designated as
fair value
hedges		Of which designated as
cash flow hedges
(€ million)202220232024202520262027 and laterTotalFair
value		Notional
amount		Fair
value		Notional
amount		Fair
value		Of which
recognized
in equity
Interest rate swaps
pay capitalized EONIA/receive 0.06%
2,000 — — — — — 2,000 10 2,000 10 — — — 
pay -0.57%/receive capitalized EONIA
600 — — — — — 600 1 — — 600 1 — 
pay SOFR USD/receive 1.03%
— — — — — 440 440 (5)440 (5)— — — 
pay SOFR USD/receive 1.32%
— — — — — 440 440 3 440 3 — — — 
receive capitalized EONIA/pay 1.48%(a)
42 57 — — — — 99 (3)99 (3)— — — 
Total2,642 57 — — — 880 3,579 7 2,979 6 600 1 — 
(a) These interest rate swaps hedge fixed-rate bonds with a nominal of €99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within “Loans, advances and other long-term receivables” (see Note D.7.).

The table below shows interest rate hedging instruments in place as of December 31, 2020:
Notional amounts by expiry date as of December 31, 2020Of which
designated as
fair value
hedges		Of which designated as
cash flow hedges
(€ million)202120222023202420252026 and laterTotalFair
value		Notional
amount		Fair
value		Notional
amount		Fair
value		Of which
recognized
in equity
Interest rate swaps
pay capitalized EONIA/receive 0.06%
— 2,000 — — — — 2,000 23 2,000 23 — — — 
pay -0.57%/receive capitalized EONIA
— 600 — — — — 600 1 — — 600 1 1 
receive capitalized Eonia/pay 1.48%(a)
— 42 57 — — — 99 (4)99 (4)— — — 
Total— 2,642 57 — — — 2,699 20 2,099 19 600 1 1 
(a) These interest rate swaps hedge fixed-rate bonds with a nominal of €99 million held in a Professional Specialized Investment Fund dedicated to Sanofi and recognized within “Loans, advances and other long-term receivables” (see Note D.7.).
Disclosure of Actual or Potential Effects of Netting Arrangements
The table below is prepared in accordance with the accounting policies described in Note B.8.3.:
(€ million)202220212020
Derivative
financial
assets		Derivative
financial
liabilities		Derivative
financial
assets		Derivative
financial
liabilities		Derivative
financial
assets		Derivative
financial
liabilities
Gross carrying amounts before offset (a)206 (326)298 (85)82 (297)
Gross amounts offset (in accordance with IAS 32) (b)— — — — — — 
Net amounts as reported in the balance sheet (a) - (b) = (c)206 (326)298 (85)82 (297)
Effects of other netting arrangements (not fulfilling the IAS 32 criteria for offsetting) (d)— — 
Financial instruments(160)160 (67)67 (81)81 
Fair value of financial collateralN/AN/AN/AN/AN/AN/A
Net exposure (c) + (d)46 (166)231 (18)1 (216)